Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter Summaries of opinion (16) Apply Summaries of opinion filter Withdrawn applications (12) Apply Withdrawn applications filter Paediatric investigation plans (159) Apply Paediatric investigation plans filter Orphan designations (107) Apply Orphan designations filter Direct healthcare professional communication (21) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (5) Apply Yes filter

Authorisation status

Authorised (359) Apply Authorised filter Refused (3) Apply Refused filter Withdrawn (38) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (16) Apply European Commission final decision filter Under evaluation (1) Apply Under evaluation filter

Referral safety status

Yes (6) Apply Yes filter

Referral type

Article 20 procedures (12) Apply Article 20 procedures filter Article 31 referrals (5) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (15) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (4) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (12) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (11) Apply Risk minimisation measures filter Suspension (2) Apply Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Additional monitoring Remove Additional monitoring filter Biosimilar Remove Biosimilar filter Accelerated assessment (44) Apply Accelerated assessment filter Conditional approval (45) Apply Conditional approval filter Exceptional circumstances (39) Apply Exceptional circumstances filter Generic (259) Apply Generic filter Orphan medicine (139) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

417 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Categories Human Remove Human filter

Medicine type Additional monitoring Remove Additional monitoring filter Biosimilar Remove Biosimilar filter

Sort by

List item

Human medicine European public assessment report (EPAR): COVID-19 Vaccine Moderna (updated)

CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021, , , Revision: 5, Authorised, Last updated: 11/06/2021
List item

Human medicine European public assessment report (EPAR): Neparvis (updated)

sacubitril, valsartan, Heart Failure
Date of authorisation: 26/05/2016, , Revision: 12, Authorised, Last updated: 11/06/2021
List item

Human medicine European public assessment report (EPAR): Skyrizi (updated)

Risankizumab, Psoriasis
Date of authorisation: 26/04/2019, , Revision: 5, Authorised, Last updated: 11/06/2021
List item

Human medicine European public assessment report (EPAR): Zejula (updated)

Niraparib (tosilate monohydrate), Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms
Date of authorisation: 16/11/2017, , , Revision: 13, Authorised, Last updated: 11/06/2021
List item

Human medicine European public assessment report (EPAR): Xerava (updated)

eravacycline, Infection, Bacterial Infections
Date of authorisation: 20/09/2018, , Revision: 2, Authorised, Last updated: 10/06/2021
List item

Human medicine European public assessment report (EPAR): Cometriq (updated)

cabozantinib, Thyroid Neoplasms
Date of authorisation: 21/03/2014, , , , Revision: 22, Authorised, Last updated: 10/06/2021
List item

Human medicine European public assessment report (EPAR): Erelzi (updated)

etanercept, Arthritis, Psoriatic, Psoriasis, Arthritis, Juvenile Rheumatoid, Arthritis, Rheumatoid, Spondylitis, Ankylosing
Date of authorisation: 23/06/2017, , , Revision: 9, Authorised, Last updated: 10/06/2021
List item

Human medicine European public assessment report (EPAR): Benlysta (updated)

belimumab, Lupus Erythematosus, Systemic
Date of authorisation: 13/07/2011, , Revision: 26, Authorised, Last updated: 09/06/2021
List item

Human medicine European public assessment report (EPAR): Zoely (updated)

Nomegestrol acetate, estradiol, Contraception
Date of authorisation: 26/07/2011, , Revision: 20, Authorised, Last updated: 09/06/2021
List item

Human medicine European public assessment report (EPAR): Hulio (updated)

adalimumab, Hidradenitis Suppurativa, Psoriasis, Crohn Disease, Uveitis, Arthritis, Rheumatoid, Colitis, Ulcerative, Spondylitis, Ankylosing, Arthritis, Psoriatic
Date of authorisation: 16/09/2018, , , Revision: 6, Authorised, Last updated: 09/06/2021
List item

Human medicine European public assessment report (EPAR): Talzenna (updated)

talazoparib, Breast Neoplasms
Date of authorisation: 20/06/2019, , Revision: 4, Authorised, Last updated: 09/06/2021
List item

Human medicine European public assessment report (EPAR): Nepexto (updated)

etanercept, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Arthritis, Psoriatic, Spondylarthropathies, Spondylitis, Ankylosing, Psoriasis
Date of authorisation: 20/05/2020, , , Revision: 4, Authorised, Last updated: 09/06/2021
List item

Human medicine European public assessment report (EPAR): Inrebic (updated)

fedratinib dihydrochloride monohydrate, Myeloproliferative Disorders, Primary Myelofibrosis
Date of authorisation: 08/02/2021, , , Authorised, Last updated: 09/06/2021
List item

Human medicine European public assessment report (EPAR): Ibrance (updated)

palbociclib, Breast Neoplasms
Date of authorisation: 09/11/2016, , Revision: 12, Authorised, Last updated: 09/06/2021
List item

Human medicine European public assessment report (EPAR): Xeljanz (updated)

tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013, , , Revision: 18, Authorised, Last updated: 08/06/2021
List item

Human medicine European public assessment report (EPAR): Keytruda (updated)

Pembrolizumab, Melanoma, Hodgkin Disease, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urologic Neoplasms, Squamous Cell Carcinoma of Head and Neck
Date of authorisation: 17/07/2015, , Revision: 35, Authorised, Last updated: 07/06/2021
List item

Human medicine European public assessment report (EPAR): Ketoconazole HRA (updated)

Ketoconazole, Cushing Syndrome
Date of authorisation: 18/11/2014, , , , Revision: 10, Authorised, Last updated: 07/06/2021
List item

Human medicine European public assessment report (EPAR): Nexpovio (updated)

Selinexor, Multiple Myeloma
Date of authorisation: 26/03/2021, , , Authorised, Last updated: 07/06/2021
List item

Human medicine European public assessment report (EPAR): Quofenix (updated)

delafloxacin meglumine, Skin Diseases, Bacterial
Date of authorisation: 16/12/2019, , Revision: 3, Authorised, Last updated: 04/06/2021
List item

Human medicine European public assessment report (EPAR): Polivy (updated)

polatuzumab vedotin, Lymphoma, B-Cell
Date of authorisation: 16/01/2020, , , , Revision: 3, Authorised, Last updated: 04/06/2021
List item

Human medicine European public assessment report (EPAR): Rinvoq (updated)

upadacitinib, Arthritis, Rheumatoid
Date of authorisation: 16/12/2019, , Revision: 4, Authorised, Last updated: 04/06/2021
List item

Human medicine European public assessment report (EPAR): Ontozry (updated)

cenobamate, Epilepsy
Date of authorisation: 26/03/2021, , Revision: 1, Authorised, Last updated: 03/06/2021
List item

Human medicine European public assessment report (EPAR): Xospata (updated)

gilteritinib fumarate, Leukemia, Myeloid, Acute
Date of authorisation: 24/10/2019, , , Revision: 1, Authorised, Last updated: 03/06/2021
List item

Human medicine European public assessment report (EPAR): Comirnaty (updated)

Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020, , , Revision: 8, Authorised, Last updated: 03/06/2021
List item

Human medicine European public assessment report (EPAR): Kesimpta (updated)

ofatumumab, Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 26/03/2021, , Revision: 1, Authorised, Last updated: 02/06/2021